Literature DB >> 31046452

Developing a mouse model of acute encephalopathy using low-dose lipopolysaccharide injection and hyperthermia treatment.

Hirofumi Kurata1,2,3, Kengo Saito1, Fumiaki Kawashima1, Takuya Ikenari1, Masayoshi Oguri4, Yoshiaki Saito2, Yoshihiro Maegaki2, Tetsuji Mori1.   

Abstract

IMPACT STATEMENT: Acute encephalopathy (AE), mainly reported in East Asia, is classified into four categories based on clinical and neuropathological findings. Among them, AE caused by cytokine storm is known as the severest clinical entity that causes cerebral edema with poor prognosis. Because suitable and convenient model animal of AE had not been developed, the treatment of patients with AE is not established. In the present study, we established a simple and convenient protocol to mimic AE due to cytokine storm. Our model animal should be useful to elucidate the pathogenesis of AE.

Entities:  

Keywords:  Hyperthermia; acute encephalopathy; blood–brain barrier; lipopolysaccharide; seizure; vasogenic edema

Mesh:

Substances:

Year:  2019        PMID: 31046452      PMCID: PMC6567586          DOI: 10.1177/1535370219846497

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  62 in total

1.  Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic injury.

Authors:  S Eklind; C Mallard; A L Leverin; E Gilland; K Blomgren; I Mattsby-Baltzer; H Hagberg
Journal:  Eur J Neurosci       Date:  2001-03       Impact factor: 3.386

2.  Haemorrhagic shock and encephalopathy syndrome: neurological course and predictors of outcome.

Authors:  B Thébaud; B Husson; Y Navelet; G Huault; P Landrieu; D Devictor; G Sebire
Journal:  Intensive Care Med       Date:  1999-03       Impact factor: 17.440

3.  Influenza virus-induced encephalopathy: clinicopathologic study of an autopsied case.

Authors:  M Takahashi; T Yamada; Y Nakashita; H Saikusa; M Deguchi; H Kida; M Tashiro; T Toyoda
Journal:  Pediatr Int       Date:  2000-04       Impact factor: 1.524

4.  Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy.

Authors:  H Aiba; M Mochizuki; M Kimura; H Hojo
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

5.  Astrocytic clasmatodendrosis in hippocampal organ culture.

Authors:  R E Hulse; J Winterfield; P E Kunkler; R P Kraig
Journal:  Glia       Date:  2001-02       Impact factor: 7.452

6.  Encephalitis and encephalopathy associated with an influenza epidemic in Japan.

Authors:  Tsuneo Morishima; Takehiro Togashi; Shyumpei Yokota; Yoshinobu Okuno; Chiaki Miyazaki; Masato Tashiro; Nobuhiko Okabe
Journal:  Clin Infect Dis       Date:  2002-08-07       Impact factor: 9.079

7.  Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia.

Authors:  Demetrios J Sahlas; Juan M Bilbao; Richard H Swartz; Sandra E Black
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

8.  The role of swollen astrocytes in human brain lesions after edema--an immunohistochemical study using formalin-fixed paraffin-embedded sections.

Authors:  N Arai
Journal:  Neurosci Lett       Date:  1992-04-13       Impact factor: 3.046

9.  Concentric structure of thalamic lesions in acute necrotizing encephalopathy.

Authors:  M Mizuguchi; M Hayashi; I Nakano; M Kuwashima; K Yoshida; Y Nakai; M Itoh; S Takashima
Journal:  Neuroradiology       Date:  2002-04-04       Impact factor: 2.804

10.  Apoptosis and microglial activation in influenza encephalopathy.

Authors:  Yoshiko Nakai; Masayuki Itoh; Masashi Mizuguchi; Hiroshi Ozawa; Etsuo Okazaki; Yasutsugu Kobayashi; Mitsuo Takahashi; Kyoichi Ohtani; Akira Ogawa; Michihiko Narita; Takehiro Togashi; Sachio Takashima
Journal:  Acta Neuropathol       Date:  2002-12-20       Impact factor: 17.088

View more
  1 in total

1.  Improvement in Double Staining With Fluoro-Jade C and Fluorescent Immunostaining: FJC Staining Is Not Specific to Degenerating Mature Neurons.

Authors:  Takuya Ikenari; Tatsuya Kawaguchi; Rei Ota; Miki Matsui; Ryota Yoshida; Tetsuji Mori
Journal:  J Histochem Cytochem       Date:  2021-08-31       Impact factor: 4.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.